Boryung Pharm (003850) — Cash Flow Reinvestment Rate
Boryung Pharm (003850) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting ₩6.89 Billion (capex ₩4.92 Billion plus investments ₩-1.97 Billion) from operating cash flow of ₩48.95 Billion. Explore 003850 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Boryung Pharm Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Boryung Pharm across 12 annual periods. Also explore balance sheet size of Boryung Pharm for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Boryung Pharm (2009–2024)
Year-by-year capital reinvestment analysis for Boryung Pharm. For live market cap and broader valuation context, see market value of Boryung Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | ₩21.02 Billion | ₩80.56 Billion | ₩20.05 Billion | ▼ -79.0% |
| 2023 | 1.24x | ₩52.51 Billion | ₩42.22 Billion | ₩23.35 Billion | ▼ -49.9% |
| 2022 | 2.48x | ₩69.06 Billion | ₩27.81 Billion | ₩20.28 Billion | ▲ +329.3% |
| 2021 | 0.58x | ₩34.80 Billion | ₩60.17 Billion | ₩16.13 Billion | ▼ -70.4% |
| 2020 | 1.95x | ₩87.43 Billion | ₩44.74 Billion | ₩18.27 Billion | ▲ +21.7% |
| 2019 | 1.61x | ₩75.50 Billion | ₩47.00 Billion | ₩67.02 Billion | ▲ +14.0% |
| 2018 | 1.41x | ₩54.83 Billion | ₩38.91 Billion | ₩54.83 Billion | ▼ -77.7% |
| 2016 | 6.33x | ₩59.22 Billion | ₩9.36 Billion | ₩26.83 Billion | ▲ +1065.3% |
| 2012 | 0.54x | ₩9.98 Billion | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩14.17 Billion | ₩9.19 Billion | ₩14.16 Billion | ▲ +23.6% |
| 2010 | 1.25x | ₩30.08 Billion | ₩24.12 Billion | ₩29.77 Billion | ▼ -61.5% |
| 2009 | 3.24x | ₩11.64 Billion | ₩3.59 Billion | ₩11.28 Billion | — |